| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 29.951 | 33.830 | 32.258 | 37.879 | 53.450 | 54.604 | 57.471 | 63.698 | 77.836 | 85.772 |
| Total Income - EUR | 30.442 | 33.912 | 32.337 | 37.921 | 53.451 | 54.605 | 59.494 | 63.700 | 77.975 | 85.773 |
| Total Expenses - EUR | 19.521 | 20.934 | 23.821 | 28.331 | 26.891 | 26.622 | 39.130 | 46.095 | 43.717 | 45.485 |
| Gross Profit/Loss - EUR | 10.921 | 12.978 | 8.516 | 9.590 | 26.560 | 27.982 | 20.363 | 17.605 | 34.258 | 40.288 |
| Net Profit/Loss - EUR | 10.020 | 12.640 | 6.850 | 9.211 | 26.028 | 27.657 | 19.858 | 17.166 | 33.665 | 38.094 |
| Employees | 2 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Dr. Polk Ingrid Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.028 | 4.977 | 4.892 | 4.803 | 4.710 | 4.620 | 18.342 | 13.788 | 9.149 | 4.861 |
| Current Assets | 54.147 | 33.757 | 24.964 | 19.543 | 32.157 | 33.076 | 19.406 | 27.842 | 44.602 | 45.904 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 47.463 | 32.022 | 23.908 | 17.951 | 18.631 | 18.490 | 16.765 | 21.892 | 40.843 | 39.675 |
| Cash | 6.685 | 1.735 | 1.056 | 1.592 | 13.526 | 14.586 | 2.641 | 5.950 | 3.759 | 6.229 |
| Shareholders Funds | 31.136 | 12.729 | 7.105 | 9.524 | 26.096 | 27.726 | 20.083 | 17.236 | 34.069 | 38.977 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 28.039 | 26.004 | 22.751 | 14.864 | 10.771 | 9.970 | 17.664 | 24.394 | 19.682 | 11.787 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Dr. Polk Ingrid Srl